Walter,
Your comment about Mark and Molycorp is way off base and a complete lack of history and knowledge what happened in the past with rare earths , China and Mountain Pass. The USA made a huge strategic mistake and is not going to make the same mistake again. Listen to the conferences this week in DC
I have been in the REE sector for years. The reputation of mark smith is abysmal. But i do understand your pov. Never let down a friend. But business wise he is a joke and we all know it.
Perhaps he should have spend all his time on niocorp instead of being on the board of other companies as well. Mark smith couldnt even raise capital in the usa after his reputation was shattered to pieces and had to find people in belgium.
Well, the americans amongst will know this. Americans are a pride group of people and if a company can become a national pride the american gladly invest in it. As a proud american.
But instead he had to go overseas, coz the no one in states believed him. 15 years later still no deal. Good investment advice by you walter.
Oh and the stellantis claim is on short term a good one. But in the long rum they will back out on the moment the operational costs rises and the profit margin sink. The first signs of that are showing already if you have any understanding of the market.
Tip look at the china- north korea REE alliance.
The dominance will never end and prices will drop significantly in a few years. The deal with stellantis between niocorp will not hold. Same thing with stellantis and mux.
To resume
2011 walter adviced niocorp. 2024 no deal
Bioaegis 2021-2022 would be the year. No success. 2030 earliest.
Lwlg still no deal
Biotech company 2021. Up list to the nasdaq 2022. Billion dollar venture. Bankrupt.
Awesome track record.
